The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Accelerating the Development and Delivery of

Effective Oncology Treatments

to Patients

 

Cancer Drug Development Forum (CDDF) is a neutral, non–competitive platform for

multi-stakeholder discussions and collaboration in the development of cancer drugs.

 

CANCER DRUG DEVELOPMENT FORUM

The leading non-competitive drug development platform working to stimulate the advancement and accessibility of cancer treatment.

Unique Multi-Stakeholder Platform

Patients

Patients are the cornerstone of CDDF’s mission and central to our multi-stakeholder discussions. Patients and advocacy groups are invited to join the CDDF multi-stakeholder community and make their voices heard. Check out collaborative opportunities and grants available to patients.

Industry

The CDDF provides the healthcare industry with unique opportunities to collaborate with diverse stakeholders and take part in open dialogue to accelerate oncology drug development. Discover the CDDF Industry Membership Program and engage with key experts in oncology.

Academia

The CDDF fosters advancement and innovation in cancer research by creating a collaborative platform for academics to share knowledge and expertise with a multi-stakeholder audience. Join CDDF’s discussions on the latest developments and explore opportunities to contribute.

Regulators & HTAs

The CDDF convenes discussions on key topics in oncology, fostering a balanced exchange of perspectives. Regulators and HTA agencies can gain valuable insights and stay informed on emerging trends through our productive dialogue. Explore collaboration opportunities and join our community.

[Executive Summary: CDDF-EORTC Joint Workshop on Innovation and Access in Rare Cancers (23-24 September 2024, Amsterdam, NL)]

The Cancer Drug Development Forum (CDDF) is delighted to announce that the executive summary of its recent workshop on Rare Cancers has been published today and is available to all stakeholders. This collaborative initiative between CDDF and EORTC focused on...

CDDF Job Opening: Community & Communication Coordinator

The Cancer Drug Development Forum (CDDF) is seeking a talented Community & Communication Coordinator to be part of our dynamic team in Brussels. Join the CDDF team to contribute to a meaningful mission that accelerates the delivery of effective cancer treatments....

Key Takeaways from the CDDF-EORTC Workshop on Innovation and Access in Rare Cancers (23-24 Sep 2024, Amsterdam)

The first day of the CDDF workshop on Rare Cancers brought together a diverse group of stakeholders into open, constructive discussions in order to improve access to innovative therapies for patients with rare cancers. Here are the key takeaways from Day 1’s program:...

🔔 📢 Key Takeaways from the CDDF-ESMO Joint Session, “Regulatory Challenges in Clinical Cancer Drug Development” (16 Sep 2024)

The CDDF & ESMO educational session on "Regulatory Challenges in Clinical Cancer Drug Development" took place on 16 September 2024 at ESMO 2024. In this session, Aaron E. Sosa Mejia (Danish Medicines Agency) and Audrey Wolf (EFPIA) gave presentations followed by a...

[🔔 📣 Call for pharmaceutical companies to join in the CDDF Diversity Initiative]

We are delighted to announce that the Cancer Drug Development Forum (CDDF) has launched its initiative on diversity in oncology clinical trials. CDDF cordially invites pharmaceutical companies to participate in this collaborative effort to support the planning and...

ACT EU: Stakeholder Presentation on Critical Use-Cases at MSP Advisory Group Meeting (4 July 2024)

On 4 July 2024, CDDF participated in a stakeholder presentation focused on critical use-cases at Multi-Stakeholder Platform (MSP) Advisory Group meeting. The session aimed to identify and discuss real-world challenges faced by stakeholder groups within the European...

[🔔 📢 Key Takeaways from the CDDF Webinar on “Bayesian Approaches in Drug Development”]

The Cancer Drug Development Forum (CDDF) held a live webinar on Bayesian Approaches in Drug Development on 11 July 2024. In this webinar, Rob Hemmings (Consilium) gave an insightful talk followed by a Q&A discussion moderated by Axel Glasmacher (CDDF) and Eva...

🔔 📢 NEW PUBLICATION: Empowering Effective Biomarker-Driven Precision Oncology: A Call to Action (Lawler et al., 2024)

The Cancer Drug Development Forum (CDDF) is delighted to announce that a white paper, “Empowering Effective Biomarker-Driven Precision Oncology: A Call to Action” has been published in European Journal of Cancer (Vol 209, September 2024). This paper has been developed...

🔔 HMA/EMA Multi-stakeholder Workshop on Artificial Intelligence – 5 Nov 2024

Check out the hybrid joint HMA/EMA multi-stakeholder workshop on Artificial Intelligence (AI) that will be held on 5 November 2024. The objectives of the workshop is to provide an update on the state-of-the-art of AI developments with keynote speakers: Update...

[🔔 📢 Key Takeaways from the CDDF Webinar on “Cancer Medicines Forum: Advancing Cancer Treatment Optimization Across Europe”]

The Cancer Drug Development Forum (CDDF) held a live webinar on Cancer Medicines Forum on 25 June 2024. In this webinar, Denis Lacombe (EORTC, BE) provided an interesting talk followed by a Q&A discussion moderated by Rosa Giuliani (CDDF, UK) and Daniel Goldstein...

CDDF Webinar: Bayesian Approaches in Drug Development (July 2024)

The recording of the recent CDDF webinar on Bayesian Approaches in Drug Development is available here. Enjoy the insightful talks from DRob Hemmings (Consilium, UK) followed by an interactive Q&A session.

CDDF & Oncology News

Check out the recent updates within the CDDF and the latest news in the community of cancer research

CDDF Brochure

Access the CDDF Brochure here

 

Join the CDDF community to find ways to accelerate oncology drug development and deliver optimal treatment to cancer patients

COLLABORATION IS THE KEY

TO IMPROVING OUTCOMES

FOR CANCER PATIENTS

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70